[
    [
        {
            "time": "",
            "original_text": "天坛生物(600161)：疫情影響上半年業績 長期綜合競爭力持續提升",
            "features": {
                "keywords": [
                    "天坛生物",
                    "疫情",
                    "上半年业绩",
                    "长期竞争力",
                    "提升"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "天坛生物(600161)：疫情影響上半年業績 長期綜合競爭力持續提升",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]